HDAC9 and glioblastoma: In line with our results, MYC modulation has been identified as a molecular readout of HDAC inhibition in acute myeloid leukemia cells [32], and the inhibition of MYC transcription by panobinostat has recently been described in glioblastoma models as well [33].